Article

Multimodal approach intriguing for enhancing antiPVR pharmacologicaltherapy

Combination pharmacological therapy offers an appealing strategy forimproving outcomes after retinal detachment surgery, said Mark S. Blumenkranz,MD.The concept of using multimodal regimens stems from understanding themechanisms for the development of proliferative vitreoretinopathy (PVR)and aims to inhibit the pathway at more than one point.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.